terbinafine hypochloride + terbinafine Tablets, film coated 281,25 mg 250 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Egypt
Manufacturer #1403
This company, headquartered in the Middle East, has been operating for over two decades, focusing on both human and veterinary pharmaceuticals. They produce a range of products including prescription and over-the-counter medications, and leverage a team of skilled pharmacists, veterinarians, marketing and sales experts to deliver quality products. The company has a strong commitment to providing affordable and safe healthcare solutions. Their primary therapy areas are not clearly stated, but their commitment to quality products suggests a focus on general health and wellness, potentially including areas like pain management and infection control. They manufacture a variety of dosage forms including solids, injectables, and liquids. The company operates under EU and USA GMP regulations, ensuring adherence to international standards.

Manufacturer usually replies in 44 days

None